Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
Chris Lange
Analyst Avery Bedows of Loup Ventures begins a series of articles describing a new class of devices in the area of consumer neurotechnology.
Paul Ausick